DBV Technologies | DBVT - Ordinary Share Capital

Stock Price
20.53
Daily Change
0.47 2.34%
Monthly
-0.82%
Yearly
321.56%
Q1 Forecast
19.99

DBV Technologies reported $11.65M in Ordinary Share Capital for its fiscal quarter ending in March of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Amarin USD 20.8M 28K Sep/2025
BioCryst Pharmaceuticals USD 1.9M 3K Sep/2023
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
DBV Technologies USD 11.65M 1000 Mar/2025
Esperion Therapeutics USD 112K 11K Sep/2023
Galectin Therapeutics USD 61K 0 Dec/2023
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Insmed USD 214.26M 1.67M Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Neurocrine Biosciences USD 100.1M 400K Dec/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
United Therapeutics USD 43.64M 740K Dec/2025